Pharmaceutical News

RSS

Anxiety reduction with antidepressants confirmed, long-term effects uncertain

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

30 Jan 2025

GLP-1RA initiation linked to new thyroid cancer diagnoses

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor agonists.

28 Jan 2025

Rural clinics significantly boost buprenorphine prescribing with support program

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid use disorder (OUD), only a small percentage of primary care clinicians currently prescribe medication for OUD (MOUD).

27 Jan 2025

New approach uses peptides to enhance anti-tumor drug formulations

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

24 Jan 2025

Research develops framework to compare lab, AI, and simulation data

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

24 Jan 2025

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and efficacy. While ischemic stroke rates were slightly higher, they were not statistically significant, warranting further phase 3 trials for confirmation.

23 Jan 2025

Why do people with obesity, but without diabetes, start taking semaglutide?

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing significant insurance coverage disparities.

22 Jan 2025

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been linked with behavioral side effects.

22 Jan 2025

Antidepressant fluoxetine found ineffective for early COVID-19 treatment

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

22 Jan 2025

Short-course antibiotics can be a game-changer in tackling ventilator-associated pneumonia

Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis.

21 Jan 2025

Azvudine beats paxlovid in reducing COVID-19 deaths

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with added antitumor effects observed.

21 Jan 2025

What drives acne relapse? New study explores isotretinoin outcomes

New research suggests that increasing cumulative isotretinoin dosage could significantly reduce acne recurrence and the need for retreatment, offering hope for long-term skin clarity.

20 Jan 2025

Benefits and risks of popular weight-loss drugs revealed

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.

20 Jan 2025

New Australian plant varieties could revolutionize pharmaceutical production

Years of scouring the bush and breeding work at The University of Queensland have resulted in new varieties of a native Australian plant valuable to the global pharmaceutical industry.

20 Jan 2025

Antihistamines offer new hope for erythropoietic protoporphyria-related liver disease

Chlorcyclizine shows promise in reducing protoporphyrin-IX accumulation and liver damage in erythropoietic protoporphyria, targeting histamine pathways.

20 Jan 2025

New research identifies metabolic targets to combat antibiotic-resistant bacterial infections

Targeting unique metabolic pathways in pathogens offers a novel approach to precision antibiotics, addressing the growing challenge of antimicrobial resistance.

17 Jan 2025

Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in PTPN2.

17 Jan 2025

Pioglitazone may help prevent painful skin ulcers in people with Werner syndrome

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 22 on December 2, 2024, entitled "Less frequent skin ulcers among patients with Werner syndrome treated with pioglitazone: findings from the Japanese Werner Syndrome Registry."

16 Jan 2025

Pittcon to make historic first appearance in Boston’s world-leading scientific hub

Pittcon 2025 in Boston: a landmark event uniting industry and academia to advance analytical chemistry and foster groundbreaking scientific collaboration.

From Pittcon 16 Jan 2025

Drug in breast cancer trials shows potential for treating blood cancers

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

16 Jan 2025

Previous
1
...
7
8
9
10
11
12
13
...
1447
Next

Pharmaceutical News

Anxiety reduction with antidepressants confirmed, long-term effects uncertain

GLP-1RA initiation linked to new thyroid cancer diagnoses

Rural clinics significantly boost buprenorphine prescribing with support program

New approach uses peptides to enhance anti-tumor drug formulations

Research develops framework to compare lab, AI, and simulation data

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

Why do people with obesity, but without diabetes, start taking semaglutide?

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

Antidepressant fluoxetine found ineffective for early COVID-19 treatment

Short-course antibiotics can be a game-changer in tackling ventilator-associated pneumonia

Azvudine beats paxlovid in reducing COVID-19 deaths

What drives acne relapse? New study explores isotretinoin outcomes

Benefits and risks of popular weight-loss drugs revealed

New Australian plant varieties could revolutionize pharmaceutical production

Antihistamines offer new hope for erythropoietic protoporphyria-related liver disease

New research identifies metabolic targets to combat antibiotic-resistant bacterial infections

Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency

Pioglitazone may help prevent painful skin ulcers in people with Werner syndrome

Pittcon to make historic first appearance in Boston’s world-leading scientific hub

Drug in breast cancer trials shows potential for treating blood cancers

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News